Pharmaceuticals & Biotechnology · disclosure as of 2026-09-30
Sun Pharmaceutical Industries Ltd.
Held by 592 funds in our universe · avg weight 2.23% · range -0.53% to 19.50%
Fundamentals
P/E history band: 34-38 · currently mid-range
Technicals · split/bonus-adjusted
Price as of 2026-10-23
Funds by category
Showing only Equity – ELSS (legacy) funds. clear filter
5 Equity – ELSS (legacy) funds holding this stock , sorted by the stock's weight in each fund
| Fund | Category | % of fund in this stock | As of |
|---|---|---|---|
|
ICICI Prudential Long Term Wealth Enhancement Fund
ICICI Prudential Mutual Fund |
Equity · ELSS (legacy) | 3.56% | 2026-09-30 |
|
SBI Long Term Advantage Fund - Series IV - Direct Plan - Growth
SBI Mutual Fund |
Equity · ELSS (legacy) | 3.51% | 2026-09-30 |
|
SBI Long Term Advantage Fund - Series V - Direct Plan - Growth
SBI Mutual Fund |
Equity · ELSS (legacy) | 2.98% | 2026-09-30 |
|
SBI Long Term Advantage Fund - Series VI - Direct Plan - Growth
SBI Mutual Fund |
Equity · ELSS (legacy) | 2.98% | 2026-09-30 |
|
UTI - Master Equity Plan Unit Scheme - Regular Plan - Growth
UTI Mutual Fund |
Equity · ELSS (legacy) | 0.52% | 2026-09-30 |
Holdings sourced from scheme portfolios as published by their AMCs each month under SEBI rules. "% of fund in this stock" is the position weight inside each fund, NOT the rupee value of any individual investor's exposure.